Agencia Cubana de Noticias
Líder en información nacional
A new meeting between the Cuban president and the PM with experts and scientists who have participated in the fight against the epidemic for more than a year was held on Tuesday to learn about the comprehensive care that has been offered in the country to children, adolescents and young people in response to the COVID-19.
The Young Nuclear Network of Cuba (JovNuC) is focusing its efforts this year on the creation of a multimedia on the applications of this branch in the country, to cover its evolution in the last four decades.
An intervention trial with the anti-COVID-19 Abdala vaccine candidate will begin this April in the province of Sancti Spíritus, central Cuba.
The National Institute of Oncology and Radiobiology (INOR), in Havana, one of the centers participating in the Soberana 02 intervention study, plans to conclude today the application of the first dose of this vaccine candidate to all its staff.
The application in more than 500 productive scenarios in Cuba of the bioproduct IHplus, developed by the local Indio Hatuey Pasture and Forage Station, proves effective in agricultural productions and animal health.
Cuban president Miguel Diaz-Canel Bermudez described the comprehensive medical care program offered in the country to some 26,000 patients from Ukraine, affected by the nuclear accident of April 26, 1986 in Chernobyl, as a milestone of Cuban medicine and solidarity.
Miguel Diaz-Canel, Cuban president, called today on Twitter to review the strategies to confront the COVID-19 in Havana, which currently presents a high transmission and dispersion of the SARS-CoV-2 virus.
Cuba studied 20,421 samples for COVID 19, resulting in 1,008 positive ones. The country accumulates 2,963,852 samples taken and 74,212 positive.
A group of 124 Cuban health specialists returned home Monday after having assisted Mexico in the fight against COVID-19.
Cuba studied 19,360 samples for COVID 19, resulting in 701 positive ones. The country accumulates 2,943,431 samples taken and 73,204 positive.
The Cuban biopharmaceutical industry's business group, BioCubaFarma, reported today that 101,943 people have already been vaccinated in the country with the first doses of the anti-COVID-19 candidates Soberana 02 and Abdala, during phase III of their clinical trials.
Given the rising number of people infected with COVID-19, the local health authorities have reinforced epidemiological control actions to limit further spread of the disease.
The State Center for the Control of Medicines and Medical Devices (CECMED) authorized on Saturday the Intervention Trial with the Abdala vaccine candidate, whose first stage will be carried out on Monday, March 29.
Cuba studied 19,842 samples for COVID 19, resulting in 832 positive ones. The country accumulates 2,883,123 samples taken and 70,634 positive.
Cuba is advancing towards full technological sovereignty in the diagnosis of COVID-19, with the development of several innovative projects for the national production of biotechnology inputs and products.
